نتایج جستجو برای: rad51 expression

تعداد نتایج: 874738  

2016
Adrian P. Wiegmans Mariska Miranda Shu Wen Wen Fares Al-Ejeh Andreas Möller

The molecular rationale to induce synthetic lethality, by targeting defective homologous recombination repair in triple negative breast cancer (TNBC), has proven to have several shortcomings. Not meeting the expected minimal outcomes in clinical trials has highlighted common clinical resistance mechanisms including; increased expression of the target gene PARP1, increased expression or reversio...

2016
Yong Li Fen Liu Yong Wang Donghai Li Fei Guo Liyao Xu Zhengguo Zeng Xiaojun Zhong Kejian Qian

BACKGROUND Autophagy has been reported to increase in cancer cells after radiation. However, it remains unknown whether increased autophagy as a result of radiation affects DNA damage repair and sensitizes cancer cells. In this study, the radiosensitization effect of rapamycin, a mammalian target of rapamycin inhibitor that induces autophagy, on human lung adenocarcinoma A549 cells was investig...

Journal: :Molecular cancer therapeutics 2009
Ananya Choudhury Helen Zhao Farid Jalali Shahnaz Al Rashid Jane Ran Stephane Supiot Anne E Kiltie Robert G Bristow

RAD51 is a key protein in the homologous recombination (HR) pathway of DNA double-strand break repair, and HR represents a novel target for cancer therapy. Because imatinib (Gleevec) has been reported to reduce RAD51 protein levels, we tested the clonogenic survival for RT112, H1299, PANC1, and PC3 tumor cell lines of varying p53 status and normal GM05757 normal fibroblasts after exposure to si...

2013
Chengzhi Xie Christina Drenberg Holly Edwards J. Timothy Caldwell Wei Chen Hiroto Inaba Xuelian Xu Steven A. Buck Jeffrey W. Taub Sharyn D. Baker Yubin Ge

Acute myeloid leukemia (AML) remains a challenging disease to treat and urgently requires new therapies to improve its treatment outcome. In this study, we investigated the molecular mechanisms underlying the cooperative antileukemic activities of panobinostat and cytarabine or daunorubicin (DNR) in AML cell lines and diagnostic blast samples in vitro and in vivo. Panobinostat suppressed expres...

Journal: :American journal of human genetics 2007
Antonis C Antoniou Olga M Sinilnikova Jacques Simard Mélanie Léoné Martine Dumont Susan L Neuhausen Jeffery P Struewing Dominique Stoppa-Lyonnet Laure Barjhoux David J Hughes Isabelle Coupier Muriel Belotti Christine Lasset Valérie Bonadona Yves-Jean Bignon Timothy R Rebbeck Theresa Wagner Henry T Lynch Susan M Domchek Katherine L Nathanson Judy E Garber Jeffrey Weitzel Steven A Narod Gail Tomlinson Olufunmilayo I Olopade Andrew Godwin Claudine Isaacs Anna Jakubowska Jan Lubinski Jacek Gronwald Bohdan Górski Tomasz Byrski Tomasz Huzarski Susan Peock Margaret Cook Caroline Baynes Alexandra Murray Mark Rogers Peter A Daly Huw Dorkins Rita K Schmutzler Beatrix Versmold Christoph Engel Alfons Meindl Norbert Arnold Dieter Niederacher Helmut Deissler Amanda B Spurdle Xiaoqing Chen Nicola Waddell Nicole Cloonan Tomas Kirchhoff Kenneth Offit Eitan Friedman Bella Kaufmann Yael Laitman Gilli Galore Gad Rennert Flavio Lejbkowicz Leon Raskin Irene L Andrulis Eduard Ilyushik Hilmi Ozcelik Peter Devilee Maaike P G Vreeswijk Mark H Greene Sheila A Prindiville Ana Osorio Javier Benitez Michal Zikan Csilla I Szabo Outi Kilpivaara Heli Nevanlinna Ute Hamann Francine Durocher Adalgeir Arason Fergus J Couch Douglas F Easton Georgia Chenevix-Trench

RAD51 is an important component of double-stranded DNA-repair mechanisms that interacts with both BRCA1 and BRCA2. A single-nucleotide polymorphism (SNP) in the 5' untranslated region (UTR) of RAD51, 135G-->C, has been suggested as a possible modifier of breast cancer risk in BRCA1 and BRCA2 mutation carriers. We pooled genotype data for 8,512 female mutation carriers from 19 studies for the RA...

2014
Yan Cao Yan Xu Lei Zhang Zhen Li Ying Jiang Xiao Tian Andrei Seluanov Vera Gorbunova Zhiyong Mao

Cancer therapy that specifically targets malignant cells with minimal or no toxicity to normal tissue has been a long-standing goal of cancer research. Rad51 expression is elevated in a wide range of cancers and Rad51 promoter has been used to transcriptionally target tumor cells, however, a large size of Rad51 promoter limits its application for gene therapy. To identify novel tumor-specific p...

Journal: :The Journal of veterinary medical science 2001
K Ochiai M Morimatsu N Tomizawa B Syuto

Mammary tumors are the most common neoplasm in female dogs, Canis canis, and in women. Mutations in human Brca2 confer an increased risk of female breast cancer. Previous studies have shown that the Brca2 tumor suppressor protein interacts with the recombinational repair protein Rad51. We cloned the full-length cDNA of the canine homologues of Brca2 and Rad51 to obtain a basis for studying thei...

2005
Isabelle Cousineau Christine Abaji Abdellah Belmaaza

The breast/ovarian cancer susceptibility proteins BRCA1 and BRCA2 maintain genome stability, at least in part, through a functional role in DNA damage repair. They both colocalize with RAD51 at sites of DNA damage/replication and activate RAD51-mediated homologous recombination repair of DNA double-strand breaks (DSB). Whereas BRCA2 interacts directly with and regulates RAD51, the role of BRCA1...

2017
Chao Zhang Bing Wang Lei Li Yawei Li Pengzhi Li Guohua Lv

Surgery followed by radiotherapy is the standard treatment for chordomas, which are a rare but low-grade type of bone cancer arising from remnants of the embryonic notochord. However, disease recurrence following radiotherapy is common, most likely due to endogenous DNA repair mechanisms that promote cell survival upon radiation strikes. The ataxia telangiectasia mutated/ataxia telangiectasia m...

Journal: :Oncology reports 2016
Keisuke Ihara Satoru Yamaguchi Nozomi Ueno Yukiko Tani Yosuke Shida Hideo Ogata Yasushi Domeki Kentaro Okamoto Masanobu Nakajima Kinro Sasaki Takashi Tsuchioka Hiroyuki Mitomi Hiroyuki Kato

DNA intrastrand cross-linking agents such as oxaliplatin induce DNA double-strand breaks (DSBs) during DNA repair and replication. In the present study, we hypothesized that DNA intrastrand cross-linking agents may significantly benefit colorectal cancer patients with deficiencies in DSB repair. Seventy-eight patients with metastatic or recurrent colorectal cancer who had measurable target lesi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید